Up­dat­ed: Pa­tient dies in Rock­et gene ther­a­py tri­al, which is put on clin­i­cal hold by FDA

Rock­et Phar­ma­ceu­ti­cals said Tues­day morn­ing that a pa­tient in its gene ther­a­py tri­al for Danon dis­ease died af­ter re­ceiv­ing a nov­el im­mune sup­pres­sion drug, rais­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER